Glucagon: acute actions on hepatic metabolism

[1]  T. Hardy,et al.  Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies , 2015, Diabetes Care.

[2]  M. Sammons,et al.  Recent progress in the development of small-molecule glucagon receptor antagonists. , 2015, Bioorganic & medicinal chemistry letters.

[3]  H. Fu,et al.  Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes , 2015, Diabetes, obesity & metabolism.

[4]  L. Gaspers,et al.  Calcium-dependent regulation of glucose homeostasis in the liver. , 2014, Cell calcium.

[5]  Margarita Fernández,et al.  Glucagon Regulation of Oxidative Phosphorylation Requires an Increase in Matrix Adenine Nucleotide Content through Ca2+ Activation of the Mitochondrial ATP-Mg/Pi Carrier SCaMC-3* , 2013, The Journal of Biological Chemistry.

[6]  Margaret S. Wu,et al.  Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist , 2012, PloS one.

[7]  A. Cherrington,et al.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.

[8]  D. Accili,et al.  Hormonal regulation of hepatic glucose production in health and disease. , 2011, Cell metabolism.

[9]  S. Qureshi,et al.  Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice , 2011, Diabetologia.

[10]  B. Glaser,et al.  Glucagonoma and the glucagonoma syndrome – cumulative experience with an elusive endocrine tumour , 2011, Clinical endocrinology.

[11]  M. Birnbaum,et al.  Essential Regulation of Cell Bioenergetics by Constitutive InsP3 Receptor Ca2+ Transfer to Mitochondria , 2010, Cell.

[12]  J. Gerich,et al.  The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications. , 2007, Endocrine reviews.

[13]  M. Magnuson,et al.  Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. , 2007, Cell metabolism.

[14]  B. Monia,et al.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. , 2004, Diabetes.

[15]  K. Petersen,et al.  Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans , 2001, Diabetologia.

[16]  R. Rizza,et al.  Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. , 2000, The Journal of clinical endocrinology and metabolism.

[17]  M. Stumvoll,et al.  Hormonal control of renal and systemic glutamine metabolism. , 2000, The Journal of nutrition.

[18]  T. Sakaguchi,et al.  Flux of the l-Serine Metabolism in Rat Liver , 1999, The Journal of Biological Chemistry.

[19]  L. Cynober,et al.  A Na+‐DEPENDENT SYSTEM A AND ASC‐INDEPENDENT AMINO ACID TRANSPORT SYSTEM STIMULATED BY GLUCAGON IN RAT HEPATOCYTES , 1999, Cell biology international.

[20]  G. Barritt,et al.  Protein kinase A regulates the disposition of Ca2+ which enters the cytoplasmic space through store-activated Ca2+ channels in rat hepatocytes by diverting inflowing Ca2+ to mitochondria. , 1998, The Biochemical journal.

[21]  K. Nair,et al.  Evidence for a catabolic role of glucagon during an amino acid load. , 1996, The Journal of clinical investigation.

[22]  P. Flakoll,et al.  The role of glucagon in the control of protein and amino acid metabolism in vivo. , 1994, Metabolism: clinical and experimental.

[23]  C. Uchida,et al.  Regulation by glucagon of serine: pyruvate/alanine: glyoxylate aminotransferase gene expression in cultured rat hepatocytes. , 1994, The Journal of biological chemistry.

[24]  S. Joseph,et al.  Phosphorylation of the inositol trisphosphate receptor in isolated rat hepatocytes. , 1993, The Journal of biological chemistry.

[25]  K. Lanoue,et al.  Sites of action of glucagon and other Ca2+ mobilizing hormones on the malate aspartate cycle. , 1988, Archives of biochemistry and biophysics.

[26]  N. Oyama,et al.  Ca2+-dependent activation of the malate-aspartate shuttle by norepinephrine and vasopressin in perfused rat liver. , 1988, Archives of biochemistry and biophysics.

[27]  A. Halestrap,et al.  Evidence that the flux control coefficient of the respiratory chain is high during gluconeogenesis from lactate in hepatocytes from starved rats. Implications for the hormonal control of gluconeogenesis and action of hypoglycaemic agents. , 1987, Biochemical Journal.

[28]  R. Gebhardt,et al.  Hormonal regulation of amino acid transport system N in primary cultures of rat hepatocytes. , 1987, European journal of biochemistry.

[29]  L. Combettes,et al.  Glucagon and vasopressin interactions on Ca2+ movements in isolated hepatocytes. , 1986, The Biochemical journal.

[30]  J. Mccormack,et al.  Studies on the activation of rat liver pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase by adrenaline and glucagon. Role of increases in intramitochondrial Ca2+ concentration. , 1985, The Biochemical journal.

[31]  L. Breton,et al.  Effects of glucagon on basal metabolic rate and oxidative phosphorylation of rat liver mitochondria. , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[32]  T. Claus,et al.  Regulation of rat liver fructose 2,6-bisphosphatase. , 1982, The Journal of biological chemistry.

[33]  S. Joseph,et al.  Increased activity of phosphate-dependent glutaminase in liver mitochondria as a result of glucagon treatment of rats. , 1981, The Biochemical journal.

[34]  D. Mickey,et al.  Rapid action of glucagon on hepatic mitochondrial calcium metabolism and respiratory rates. , 1980, Biochimica et biophysica acta.

[35]  N. J. Edgell,et al.  Role of calcium ions in the regulation of intramitochondrial metabolism. Effects of Na+, Mg2+ and ruthenium red on the Ca2+-stimulated oxidation of oxoglutarate and on pyruvate dehydrogenase activity in intact rat heart mitochondria. , 1980, The Biochemical journal.

[36]  R. Denton,et al.  The role of calcium in the regulation of mitochondrial metabolism. , 1980, Biochemical Society transactions.

[37]  A. Le Cam,et al.  Insulin and glucagon stimulation of amino acid transport in isolated rat hepatocytes. Synthesis of a high affinity component of transport. , 1979, The Journal of biological chemistry.

[38]  T. Aoki,et al.  The effects of glucagon on protein metabolism in normal man. , 1979, Surgery.

[39]  V. Titanji,et al.  Regulation in vitro of rat liver pyruvate kinase by phosphorylation-dephosphorylation reactions, catalyzed by cyclic-AMP dependent protein kinases and a histone phosphatase. , 1976, Biochimica et biophysica acta.

[40]  Russell K Yamazaki Glucagon stimulation of mitochondrial respiration. , 1975, The Journal of biological chemistry.

[41]  A. Gotto,et al.  Basal and Postprotein Insulin and Glucagon Levels During a High and Low Carbohydrate Intake and Their Relationships to Plasma Triglycerides , 1975, Diabetes.

[42]  P. Cohen Activation and phosphorylation of the subunits of phosphorylase kinase. , 1972, The Biochemical journal.

[43]  C. Park,et al.  Control of gluconeogenesis in liver. IV. Differential effects of fatty acids and glucagon on ketogenesis and gluconeogenesis in the perfused rat liver. , 1969, The Journal of biological chemistry.

[44]  C. Park,et al.  Control of gluconeogenesis in liver. 3. Effects of L-lactate, pyruvate, fructose, glucagon, epinephrine, and adenosine 3',5'-monophosphate on gluconeogenic intermediates in the perfused rat liver. , 1969, The Journal of biological chemistry.

[45]  C. Park,et al.  Control of gluconeogenesis in liver. II. Effects of glucagon, catecholamines, and adenosine 3',5'-monophosphate on gluconeogenesis in the perfused rat liver. , 1968, The Journal of biological chemistry.

[46]  J. Sokal Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. , 1966, Endocrinology.

[47]  H. Fu,et al.  A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes , 2015 .

[48]  G. J,et al.  Control of Gluconeogenesis in Liver , 2003 .

[49]  J. Exton Mechanisms of hormonal regulation of hepatic glucose metabolism. , 1987, Diabetes/metabolism reviews.

[50]  L. L. Miller Some direct actions of insulin, glucagon, and hydrocortisone on the isolated perfused rat liver. , 1961, Recent progress in hormone research.

[51]  Miller Ll Some direct actions of insulin, glucagon, and hydrocortisone on the isolated perfused rat liver. , 1961 .

[52]  E. Sutherland,et al.  The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. , 1957, The Journal of biological chemistry.

[53]  E. Sutherland,et al.  The relationship of epinephrine and glucagon to liver phosphorylase. I. Liver phosphorylase; preparation and properties. , 1956, The Journal of biological chemistry.

[54]  E. Sutherland,et al.  The relationship of epinephrine and glucagon to liver phosphorylase. III. Reactivation of liver phosphorylase in slices and in extracts. , 1956, The Journal of biological chemistry.